No statistically significant difference was found when the NAFLD group was compared in terms of ACE gene polymorphism by grade (p = 0.42; Table 4) and by stage (p = 0.92; Table 5). This evidence concerns the gene ACE and metabolic dysfunction-associated steatotic liver disease.